Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch
of a new opioid emergency awareness public education campaign to
prepare people across the country to help save a life with the
‘Lay, Spray, Stay’ method. Sponsored by Emergent and created in
partnership with SAFE Project, a national nonprofit combating
substance use, overdoses and addiction, the campaign stars Pro
Football Hall of Famer, Emmitt Smith, in a series of public
awareness video and radio segments. The effort supports Emergent’s
national Ready to Rescue initiative, which breaks down the stigma
associated with accidental opioid poisonings and informs Americans
on the availability and use of NARCAN® Nasal Spray to help save a
life.
Naloxone, the active ingredient in NARCAN® Nasal Spray, is a
medication designed to rapidly reverses the effects of an opioid
poisoning and is the standard of care for opioid overdose reversal.
It is available over the counter and can be accessed at leading
pharmacies and grocery stores nationwide, as well as online
retailers.
“More than 100,000 people lost their lives to drug overdoses in
2023, and a majority were caused by opioids and synthetic opioids
like fentanyl,” said Paul Williams, senior vice president and
products business head at Emergent. “These individuals are loved
ones, friends, community members, colleagues, neighbors, children.
The tragic rate of fatal opioid emergencies is why we continue to
educate the public on preparedness and increase widespread
awareness around ‘Lay, Spray, Stay’ – three important steps that
are critical when responding to an opioid emergency.”
“Through our Ready to Rescue initiative I’ve had the opportunity
to meet so many people who want to step up and help in an opioid
emergency; they just need the information and tools to do so,” said
Emmitt Smith. “Most opioid-related deaths are preventable, and by
raising awareness of the ‘Lay, Spray, Stay’ method, more people
will be prepared to help save a life in an opioid emergency.
Together, we can make a safer world for our children and future
generations.”
Emergent partnered with SAFE Project – an organization founded
by Sandy Winnefeld, the former Chairman of the Joint Chiefs of
Staff, and his wife, Mary – when they lost their son to an
accidental overdose. SAFE Project provides tools and resources and
other support to educate the public on the importance of overcoming
the stigma relating to overdoses, as well as to encourage the
distribution and use of naloxone.
“We are proud partners for this campaign and thrilled with
Emergent’s willingness to sponsor this educational initiative,”
said Jeff Horwitz, CEO of SAFE Project. “SAFE Project is committed
to saving lives from overdoses and, like Emmitt, we appreciate that
it takes solid teamwork to make a difference. Collective action is
essential to fighting stigma, overcoming overdoses and saving
lives. Working together, we can all be Ready to Rescue!”
Learn more about the Ready to Rescue campaign and how to perform
the ‘Lay, Spray, Stay’ method in an opioid emergency at
www.readytorescue.com.
Emmitt Smith is a paid spokesperson for Emergent.
About
NARCAN® Nasal
Spray
NARCAN® Naloxone HCl Nasal Spray 4 mg is the first
FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the
emergency treatment of opioid overdose. NARCAN® Nasal Spray is
not a substitute for emergency medical care. Repeat dosing may be
necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25
years, we’ve been at work defending people from things we hope will
never happen—so we are prepared just in case they ever do. We
provide solutions for complex and urgent public health threats
through a portfolio of vaccines and therapeutics that we develop
and manufacture for governments and consumers. We also offer a
range of integrated contract development and manufacturing services
for pharmaceutical and biotechnology customers. To learn more about
how we plan to protect or enhance 1 billion lives by 2030, visit
our website and follow us
on LinkedIn, X, Instagram, Apple
Podcasts and Spotify.
About SAFE Project
SAFE Project is a national 501(c)(3) nonprofit committed to
overcoming the addiction epidemic in the United States. Established
in 2017 by Admiral James and Mary Winnefeld after the tragic loss
of their 19-year-old son Jonathan due to an opioid overdose, SAFE
Project aims to save lives impacted by substance use and mental
health challenges through overdose prevention and response,
education on stigma, and development of prevention and recovery
programs. SAFE Project also provides tailored guidance and training
within its four key initiatives: SAFE Campuses, SAFE Communities,
SAFE Workplaces, and SAFE Veterans. To learn more, please visit
safeproject.us.
Safe Harbor Statement
This press release includes forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements, other than statements of historical fact, are
forward-looking statements. We generally identify forward-looking
statements by using words like “anticipate,” “believe,” “continue,”
“could,” “estimate,” “expect,” “forecast,” “future,” “goal,”
“intend,” “may,” “plan,” “position,” “possible,” “potential,”
“predict,” “project,” “should,” “target,” “will,” “would,” and
similar expressions or variations thereof, or the negative thereof,
but these terms are not the exclusive means of identifying such
statements. Forward-looking statements are based on our current
intentions, beliefs and expectations regarding future events based
on information that is currently available. We cannot
guarantee that any forward-looking statements will be accurate.
Readers should realize that if underlying assumptions prove
inaccurate or unknown risks or uncertainties materialize, actual
results could differ materially from our expectations. Readers are,
therefore, cautioned not to place undue reliance on any
forward-looking statements. Any forward-looking statement speaks
only as of the date of this press release, and, except as required
by law, we do not undertake any obligation to update any
forward-looking statement to reflect new information, events or
circumstances.
There are a number of important factors that could cause the
company’s actual results to differ materially from those indicated
by any forward-looking statements. Readers should consider this
cautionary statement, as well as the risk factors and other
disclosures included in our periodic reports filed with
the U.S. Securities and Exchange Commission, when evaluating
our forward-looking statements.
Investor Contact: Richard S. Lindahl Executive
Vice President, CFOlindahlr@ebsi.com Media
Contact: Assal Hellmer Vice President, Communications
mediarelations@ebsi.com
References:
- Centers for Disease Control and
Prevention. Statement from CDC Chief Medical Officer Dr. Deb Houry
on 2023 Overdose Death Data. Available at:
https://www.cdc.gov/media/releases/2024/s-overdose-data.html.
Accessed July 19, 2024.
- Centers for Disease Control and
Prevention. Drug Overdose Data. National Center for Health
Statistics, National Vital Statistics System. Available at:
https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed
July 19, 2024.
A video accompanying this announcement is available
at: https://www.globenewswire.com/NewsRoom/AttachmentNg/2719b01f-2640-4af6-be4a-f72a55334667
Emergent Biosolutions (NYSE:EBS)
過去 株価チャート
から 6 2024 まで 7 2024
Emergent Biosolutions (NYSE:EBS)
過去 株価チャート
から 7 2023 まで 7 2024